Erichsenhaney6393
Recent functional studies have reported that amygdala and anterior cingulate cortex (ACC) dysfunction is a reproducible and good biomarker of major depressive disorder. When we use the activation of these regions as biomarkers of major depressive disorder, a short and simple stimulation paradigm could be preferable to reduce the burden on patients. However, negativity bias, which is the phenomenon by which negative stimuli are processed noticeably faster than positive stimuli, might affect the activation of these regions in the short and simple stimulation paradigm. Few studies have reported the relationship between the length of the stimulation paradigm and activation in the amygdala and ACC from the viewpoint of negativity bias. The purpose of this study was to assess the effects of negativity bias on the amygdala and ACC as a result of manipulating the stimulation paradigm (short-simple vs. long-complex conditions) on presenting pleasant and unpleasant pictures. Image analyses showed that the amygdala was activated during unpleasant picture presentation, regardless of the task length, but no activation was observed during pleasant picture presentation under the short-simple condition. The ACC was deactivated in both the short-simple and long-complex conditions. Region of interest analyses showed that the effect of negativity bias was prominent for the amygdala in the short-simple condition and for the ACC in the long-complex condition. In conclusion, the effects of negativity bias depend on neural regions, including the amygdala and ACC, and therefore, we should consider these effects while designing stimulation paradigms.Thalamus plays an important role in the pathogenesis of multiple sclerosis-related fatigue (MSrF). However, the thalamus is a heterogeneous structure and the specific thalamic subregions that are involved in this condition are unclear. Here, we used thalamic shape analysis for the detailed localization of thalamic abnormalities in MSrF. Using the Modified Fatigue Impact Scale, we measured fatigue in 42 patients with relapsing-remitting multiple sclerosis (MS). The thalamic shape was extracted from T1w images using an automated pipeline. We investigated the association of thalamic surface deviations with the severity of global fatigue and its cognitive, physical and psychosocial subdomains. Cognitive fatigue was correlated with an inward deformity of the left anteromedial thalamic surface, but no other localized shape deviation was observed in correlation with global, physical or psychosocial fatigue. Our findings indicate that the left anteromedial thalamic subregions are implicated in cognitive fatigue, possibly through their role in reward processing and cognitive and executive functions.
The purpose of this study is to investigate the cortical activation during passive and active training modes under different speeds of upper extremity rehabilitation robots.
Twelve healthy subjects completed the active and passive training modes at various speeds (0.12, 0.18, and 0.24 m/s) for the right upper limb. The functional near-infrared spectroscopy (fNIRS) was used to measure the neural activities of the sensorimotor cortex (SMC), premotor cortex (PMC), supplementary motor area (SMA), and prefrontal cortex (PFC).
Both the active and passive training modes can activate SMC, PMC, SMA, and PFC. The activation level of active training is higher than that of passive training. At the speed of 0.12 m/s, there is no significant difference in the intensity of the two modes. However, at the speed of 0.24 m/s, there are significant differences between the two modes in activation levels of each region of interest (ROI) (P < 0.05) (SMC F = 8.90, P = 0.003; PMC F = 8.26, P = 0.005; SMA F = 5.53, P = 0.023; PFC F = 9.160, P = 0.003).
This study mainly studied on the neural mechanisms of active and passive training modes at different speeds based on the end-effector upper-limb rehabilitation robot. Slow, active training better facilitated the cortical activation associated with cognition and motor control.See Video Abstract, http//links.lww.com/WNR/A621.
This study mainly studied on the neural mechanisms of active and passive training modes at different speeds based on the end-effector upper-limb rehabilitation robot. Slow, active training better facilitated the cortical activation associated with cognition and motor control.See Video Abstract, http//links.lww.com/WNR/A621.Hepatocyte growth factor (HGF) promotes the neurite outgrowth of sensory neurons in developmental stages, but its role in injured peripheral nerves in adult mice remains largely been unexplored. In this study, we investigated the role of HGF in the regeneration of injured peripheral nerves using cultured dorsal root ganglions (DRGs). When cells were treated with HGF protein, the length of the neurite was increased 1.4-fold compared to the untreated control group. Selleckchem Lificiguat HGF greatly increased the level of phosphorylated STAT3 at serine 727 [pSTAT3 (Ser 727)], thereby translocating the protein to the mitochondria. HGF treatment increased the activity of mitochondrial complex I. When DRGs were cultured in the presence of U0126, a pharmacological inhibitor of Erk, the HGF-mediated increase in neurite outgrowth and the level of pSTAT3 (Ser 727) were both suppressed. Taken together, these results suggest that the HGF/c-met pathway might promote neurite outgrowth by controlling mitochondrial activity through the HGF/Erk/STAT3 axis.
We attempt to investigate the biological function of the discoidin, complement C1r/C1s,Uegf, and Bmp1 and Limulus factor C, Coch, and Lgl domain-containing 2 (DCBLD2) in glioblastoma, as well as its effect on the epithelial-mesenchymal transition (EMT) process.
The public expression data of glioblastoma samples and normal brain samples from The Cancer Genome Atlas database, Genotype-Tissue Expression database and Chinese Glioma Genome Atlas database were used to analyze the expression of DCBLD2 and its relationship with the survival of patients with glioblastoma. Quantitative real-time PCR and western blot were used to evaluate mRNA and protein levels of DCBLD2. Cell viabilities were tested using Cell Counting Kit-8 and clone formation assays. Cell invasive and migratory abilities were measured by transwell assays.
DCBLD2 expression was upregulated in glioblastoma and has a significantly positive correlation with the WHO classification. In addition, high expression of DCBLD2 was closely correlated with poor prognosis in primary and recurrent patients with glioblastoma.